Establishment of an animal model for P-ANCA positive crescentic glomerulonephritis
P-ANCA阳性新月体肾小球肾炎动物模型的建立
基本信息
- 批准号:10671016
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Primary crescentic glomerulonephritis is rapidly progressive and poorly prognostic. The treatment depends mainly on glucocorticoid hormone and imuunosuppressants. Animal models play pivotal roles to establish new strategy for therapy of intractable of intractable diseases. In this study, I tried to raise severe combined immunodeficiency (SCID) mice carrying perinuclear anti-neutrophil cytoplasmic antibody (P-ANCA) and crescentic glomerulonephritis (GN).1. Association between P-ANCAGN and HLA class II genotypes.Utilizing PCR-RFLP and PCR-SSO, I determined HLA class II genotypes of 34 Japanese patients with P-ANCAGN. I found significant of P-ANCAGN with HLA-DRB1ィイD1*ィエD10803 (Odd's ratio 2.5 p<0.01) and with HLA-DQB1ィイD1*ィエD10601 (Odd's ratio 26 p<0.01), DRB1ィイD1*ィエD10803 and DQB1ィイD1*ィエD10601 are in linkage disequiribrium in Japanese population.2. Detection of human P-ANCA in patients and mice.Solid phase enzyme linked immunoadsorbent assay was used to detect human P-ANCA. In brief, pur … More ified myeloperoxidase (MPO) was immobilized on a plastic microtiter plate, sample serum was applied, wells were washed extensively, alkaline phosphatase labeled goat anti-human IgG or IgA antibody was added, and PNPP was added as substrate. The titers determined at my lab were well correlated with those from SRL laboratory.3. MPO specific T cell proliferation.Peripheral lymphocytes were cocultured with purified MPO for 7 days, and the proliferation was assayed by uptake of tritiated thymidine. No T cell specific response was demonstrated.4. SCID mouse producing P-ANCA.Peripheral lymphocytes from P-ANCAGN were transferred to 8-week-age SCID mice. The body weight, systolic and diastolic blood pressure, urine proteinuria, human IgG and IgM, and human P-ANCA were monitored every two weeks. The mice were sacrificed at 12 weeks of follow-up. Human IgG and IgM were detected in mice with human lymphocytes, but P-ANCA only in those with patient lymphocytes. The mice died before end point, and all were mice transferred patient lymphocyte. No mice showed proteinuria or hypertension suggesting P-ANCAGN, Pathological examination is under investigation. Less
原发性新月肾小球肾炎是迅速进行的,预后不佳。该治疗主要取决于糖皮质激素和肌抑制剂。动物模型扮演着关键角色,以建立治疗顽固性疾病的新策略。在这项研究中,我试图提高携带核周抗中性嗜性胞质抗体(P-ANCA)和新月肾小球肾炎(GN)的严重组合免疫缺陷(SCID)小鼠。1。 P-cancagn和HLA II类基因型之间的关联。利用PCR-RFLP和PCR-SSO,我确定了34例日本P-cancagn患者的HLA II类基因型。我发现与HLA-DRB1II D1*IE D10803(奇数比2.5 p <0.01)以及HLA-DQB1II D1*IE D10601(奇数比26 p <0.01),DRB1II D1 D1*II D10803和DQB1II D101*II d10601 II d10601,我发现了p-cancagn的意义。人口2。检测患者和小鼠的人类p-anca。固相酶连接的免疫吸附测定法用于检测人类p-anca。简而言之,将更多的骨过氧化物酶(MPO)固定在塑料微量盘板上,施加样品血清,对井进行广泛洗涤,碱性磷酸酶标记为山羊抗人类IgG或IgA抗体,并加入PNPP,并添加PNPP为substrate。在我的实验室确定的滴度与SRL实验室的滴度相关。3。将MPO特异性T细胞增殖。将外淋巴细胞与纯化的MPO共培养7天,并通过摄取tri的胸苷的摄取来分配增殖。未证明T细胞特异性响应4。 SCID小鼠产生的P-ANCA。来自P-Cancagn的外膜淋巴细胞转移到8周时代的SCID小鼠中。每两周监测体重,收缩压和舒张压,尿液蛋白尿,人IgG和IgM以及人P-anca。在随访的12周时处死小鼠。在患有人淋巴细胞的小鼠中检测到人IgG和IgM,但仅在患有患者淋巴细胞的人中P-ANCA。小鼠在终点前死亡,所有小鼠均转移患者淋巴细胞。没有小鼠表现出蛋白质症或高血压表明p- cancagn,正在研究病理检查。较少的
项目成果
期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Satoru Ogaharaら: "Effect of mismatched combinations of HLA-A antigens on graft survivai in the transplanted kidney." Transplantation Proceedings. 30(7). 3500-3501 (1998)
Satoru Ogahara 等人:“HLA-A 抗原的不匹配组合对移植肾移植物存活的影响”30(7) (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kenji Minoguchiら: "Protein tyrosine phosphorylation : A possible common signaling pathway in human Th1 and Th2 cell clones"International Archive of Allergy and lmmunology. 118(1). 30-36 (1999)
Kenji Minoguchi 等人:“蛋白质酪氨酸磷酸化:人类 Th1 和 Th2 细胞克隆中可能的常见信号传导途径”国际过敏和免疫学档案 118(1)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tomoichiro Tanaka, et al: "Increased expression of HLA-DR molecule on peripheral blood Th lymphocytes from patients with IgA nephropathy."Clinical and Experimental Nephrology. 3(3). 186-191 (1999)
Tomoichiro Tanaka 等人:“IgA 肾病患者外周血 Th 淋巴细胞上 HLA-DR 分子的表达增加。”临床和实验肾病学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tomoichiro Tanakaら: "Increased epression of HLA-DR molecule on peripheral blood Th lymphocytes from patients with IgA nephropathy." Clinical and Experimental Nephrology. 印刷中. (1999)
Tomoichiro Tanaka 等人:“IgA 肾病患者外周血 Th 淋巴细胞的 HLA-DR 分子表达增加”,《临床和实验肾病学》出版。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Satoru Ogahara, et al: "Effect of mismatched combination of HLA-A antigens on graft survival in the transplanted kidney."Transplantation Proceedings. 30(7). 3500-3501 (1998)
Satoru Ogahara 等人:“HLA-A 抗原的不匹配组合对移植肾移植物存活的影响。”移植论文集。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANEOKA Hidetoshi其他文献
KANEOKA Hidetoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KANEOKA Hidetoshi', 18)}}的其他基金
The development of faster genetic diagnosis of an inborn error of metabolism causing rhabdomyolysis and acute renal
对引起横纹肌溶解症和急性肾病的先天性代谢缺陷的快速基因诊断的发展
- 批准号:
18590918 - 财政年份:2006
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of apoptosis onto pathogenesis of neuro-Behcet's disease
细胞凋亡在神经白塞病发病机制中的作用
- 批准号:
07670735 - 财政年份:1995
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of Autoimmunity through synthetic peptides deduced from HLA allele-specific binding motifs.
通过从 HLA 等位基因特异性结合基序推导出的合成肽来调节自身免疫。
- 批准号:
05454242 - 财政年份:1993
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
P-GLYCOPROTEIN AND CYTOCHROME P450 GENOTYPE AND PHENOTYPE ON RESPONSE TO ANCA
P-糖蛋白和细胞色素 P450 基因型和表型对 ANCA 的反应
- 批准号:
7716797 - 财政年份:2008
- 资助金额:
$ 1.92万 - 项目类别:
P-GLYCOPROTEIN AND CYTOCHROME P450 GENOTYPE AND PHENOTYPE ON RESPONSE TO ANCA
P-糖蛋白和细胞色素 P450 基因型和表型对 ANCA 的反应
- 批准号:
7625574 - 财政年份:2006
- 资助金额:
$ 1.92万 - 项目类别:
P-GLYCOPROTEIN AND CYTOCHROME P450 GENOTYPE AND PHENOTYPE ON RESPONSE TO ANCA
P-糖蛋白和细胞色素 P450 基因型和表型对 ANCA 的反应
- 批准号:
7377524 - 财政年份:2005
- 资助金额:
$ 1.92万 - 项目类别:
自己免疫性肝疾患における抗HMG1/HMG2抗体の意義に関する集学的研究
抗HMG1/HMG2抗体在自身免疫性肝病中的意义的多学科研究
- 批准号:
11897011 - 财政年份:1999
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)